Pascal Prigent

Pascal Prigent serves as Chief Executive Officer at GENFIT. GENFIT operates in the biotechnology sector with approximately 210.0 employees. The company is headquartered in Paris, Ile-de-France. GENFIT generates annual revenue of 61729000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 4,101 executive contacts are available in Ile-de-France.
• • Our database includes 201,469 c suite-level executives.

Mailchimp Mandrill Outlook Microsoft Office 365 OneTrust MailJet

drug discovery drug development liver disease clinical trial aclf cholestatic diseases hepaticencephalopathy cholangiocarcinoma therapeutics diagnostics ureacycledisorder biotechnology: biological products (no diagnostic substances) health care biopharmaceuticals therapeutic solutions liver diseases rare diseases acute-on-chronic liver failure urea cycle disorders organic acidemia nash diagnostic tools clinical trials healthcare professionals patient outcomes innovative therapies unmet medical needs research & development ethics transparency market access data science healthcare sector pharmaceuticals patient management healthcare providers international market corporate responsibility clinical development biomarker discovery therapeutic programs diagnostic franchises healthcare innovation patient care regulatory expertise strategic partnerships clinical pipeline patient demographics healthcare institutions advanced treatments therapeutic candidates commercial readiness health wellness & fitness hospital & health care medical

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Pascal Prigent, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Pascal Prigent's Position in the MessageCEO Database

• •Pascal Prigent is 1 of 1 verified executive contact we track at GENFIT.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •4,045 verified executive contacts in Ile-de-France are in the database.
• •3 verified contacts work at biotechnology companies in the 210.0 employee range (same size as GENFIT).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Pascal Prigent directly?

Pascal Prigent's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at GENFIT. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Pascal Prigent work for?

Pascal Prigent is Chief Executive Officer at GENFIT, a company in the biotechnology sector with 210.0 employees. The company is based in Paris, Ile-de-France.

Can I pitch or sell to Pascal Prigent?

As Chief Executive Officer at GENFIT, Pascal Prigent is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Pascal Prigent directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Pascal Prigent in?

Pascal Prigent works in the biotechnology industry as Chief Executive Officer at GENFIT. MessageCEO provides verified contact information for executives across all major industries.

Is Pascal Prigent's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Pascal Prigent's profile is kept up-to-date with the latest available information.

Last updated: July 22, 2026